Skip to content

Comparison Of The Outcomes Of Simultaneous Laser Treatment And Injection Sclerotherapy Versus Laser Treatment Alone In Patients With Varicose Veins of Legs

Comparison Of The Outcomes Of Concomitant Truncal Laser Ablation And Tributary Foam Sclerotherapy Versus Truncal Laser Ablation Alone In Patients With Lower Extremity Venous Reflux - A Single Centre Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/04/018703
Enrollment
100
Registered
2019-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I832- Varicose veins of lower extremities with both ulcer and inflammation

Interventions

Intervention1: Concomitant EVLA and Foam Sclerotherapy: Both EVLA and foam sclerotherapy will be done simultaneously in same sitting in one group. Control Intervention1: EVLA alone: One group will rec

Sponsors

AIIMS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a. Age 18-75years, informed consent b. C2-6, Epr, A s, according to the CEAP classification (clinical, etiologic, anatomical, and pathophysiological (CEAP) ) c. Primary signs and symptoms of truncal(saphenous, accessory, non saphenous) vein incompetence/relux with reflux time of 1 sec or more on Doppler, and diameter of varicose veins more than 3mm and less than 15mm, diameter of perforator >3mm. c. an accessible vein.

Exclusion criteria

Exclusion criteria: 1. Any patient who doesnâ??t give consent for being included in the study. 2. Evidence of peripheral arterial disease 3. any previous treatment, such as surgery, EVLA, radiofrequency ablation, or FS, for ipsilateral varicosity. 4. lower limb varicosity caused by deep venous thrombosis. 5. coagulation disorder, pregnancy, lactation, current thrombosis, systemic disease, poor general health, or allergy to sodium tetradecyl sulfate (STS) 6. Contraindication to iodinated contrast media

Design outcomes

Primary

MeasureTime frame
Aberdeen Varicose Vein Questionnaire (AVVQ)Timepoint: 24 hours, 1 week, 4 weeks, 3months and 6months after procedure

Secondary

MeasureTime frame
EuroQol Group 5-Dimension Self-Report Questionnaire (EQ-5D), numerical rating scale (NRS) scores, CEAP scoreTimepoint: 24 hours, 1 week, 4 weeks, 3months and 6months after procedure

Countries

India

Contacts

Public ContactVineeta Ojha

AIIMS, NEW DELHI

sanjeevradio@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026